Antidiabetes wars: A new hope

Nature Medicine

Volumn 16, Issue 9, 2010, Pages 972-973

  Lazar, Mitchell A ^a   Scherer, Philipp E ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ADIPSIN; CD36 ANTIGEN; CYCLIN DEPENDENT KINASE 5; HIGH DENSITY LIPOPROTEIN; INSULIN SENSITIZING AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; RESISTIN; ROSIGLITAZONE; TROGLITAZONE;

ADIPOCYTE; ADIPOGENESIS; CLINICAL EVALUATION; CYTOKINE PRODUCTION; DRUG BINDING SITE; DRUG EFFICACY; DRUG MECHANISM; EDEMA; GENE EXPRESSION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIDE EFFECT; WEIGHT GAIN;

EID: 77956445002     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0910-972     Document Type: Short Survey

References (5)

1. Choi, J.H. et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5. Nature 466, 451-456 (2010).
2. Lehrke, M. & Lazar, M.A. The many faces of PPARγ. Cell 123, 993-999 (2005).
3. Gronemeyer, H., Gustafsson, J.A. & Laudet, V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3, 950-964 (2004). (Pubitemid 39534319)
4. Olefsky, J.M. and Glass, C.K. Macrophage, inflammation and insulin resistance. Ann. Rev. Physiol. 72, 219-246 (2010).
5. Vernochet, C. et al. C/EBPα and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor γ agonists. Mol. Cell Biol. 29, 4714-4728 (2010).